Abingdon Health (LON:ABDX) Releases Quarterly Earnings Results

Abingdon Health (LON:ABDX) released its earnings results on Tuesday. The company reported GBX (0.43) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Abingdon Health had a negative net margin of 40.51% and a negative return on equity of 58.27%.

Abingdon Health Stock Performance

ABDX opened at GBX 8 on Wednesday. Abingdon Health has a 1-year low of GBX 5.10 and a 1-year high of GBX 9. The company has a current ratio of 1.76, a quick ratio of 1.96 and a debt-to-equity ratio of 19.40. The company has a market cap of £20.09 million, a P/E ratio of -8.60 and a beta of 0.25. The company has a fifty day moving average price of GBX 6.60 and a two-hundred day moving average price of GBX 6.47.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.